Let’s talk – Disclaimers
1) The information on this tool is presented by Gilead Sciences for the purpose of disseminating health information free of charge for the benefit of healthcare professionals and the public, While Gilead Sciences has exercised due care in ensuring the accuracy of the material contained on this tool, the information on the tool is made available on the basis that Gilead Sciences is not providing professional advice on a particular matter.
2) This tool is not a substitute for independent professional advice. Nothing contained in this tool is intended to be used as medical advice and it is not intended to be used to diagnose, treat, cure or prevent any disease, nor should it be used for therapeutic purposes or as a substitute for a specialized health professional's advice.
3) Gilead Sciences does not accept any liability for any injury, loss or damage incurred by use of or reliance on the information provided on this tool. Gilead Sciences makes every effort to ensure the quality of the information available on this tool and updates the information regularly. Despite that the materials included in the tool is approved by local health authorities, before relying on the information on this tool, you should carefully evaluate its accuracy, currency, completeness and relevance for their purposes, and should obtain any appropriate specialized professional advice relevant to their particular circumstances.
4) Gilead Sciences cannot guarantee and assumes no legal liability or responsibility for the accuracy, currency, completeness or interpretation of the information. The material may include the views or recommendations of third parties and does not necessarily reflect the views of Gilead Science’s or indicate a commitment to a particular course of action.
5) Gilead Sciences may have access to general statistical app usage data and does not have any access to any identifiable data that is installed, upload or incorporated in the tool, and your usage of the tool is not intended to impose in any way whatsoever an obligation to promote or otherwise encourage the prescription, recommendation, purchase, supply, sale or administration of the products of Gilead Sciences or its affiliates.
6) Reporting suspected adverse reactions after authorization of the medicinal product is important. It allows continued monitoring of the benefit/risk balance of the medicinal product. Healthcare professionals and patients are asked to report any suspected adverse reactions via the national reporting schemes as applicable
7) Adverse reactions may also be reported directly to the manufacturer of the suspected product.
8) Adverse reactions related to Gilead products may be reported directly to Gilead via
Safety_FC@Gilead.com
9) For any questions related to Gilead products or therapeutic areas please contact: askgileadME@gilead.com
